Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
193
datasets available to search
ShareScore release 0.9.0
Dataset results
193 results for “CD20”
Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT01054781. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00825149. IPD Sharing: Not stated. Countries: 6. Publications: 4.
Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies
ClinicalTrials.gov study NCT02315118. IPD Sharing: Not stated. Countries: 1. Publications: 1.
B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
ClinicalTrials.gov study NCT01156909. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy of Anti-CD20 Antibodies (Rituximab Biosimilar) in the Treatment of Childhood Steroid-dependent Nephrotic Syndrome
ClinicalTrials.gov study NCT04402580. IPD Sharing: YES. Countries: 1. Publications: 2.
Anti-CD20 in Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT00036491. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00285428. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Anti-CD20 Antibodies for Treatment of SLE-PAH
ClinicalTrials.gov study NCT05828147. IPD Sharing: YES. Countries: 1. Publications: 7.
A Study Comparing the Efficacy and Safety Between I-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients
ClinicalTrials.gov study NCT02867566. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Anti-CD20 (Cluster of Differentiation Antigen 20) Therapy to Treat Metastatic Melanoma
ClinicalTrials.gov study NCT01376713. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05805943. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma
ClinicalTrials.gov study NCT01569750. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Rituximab+mVPDL for CD20(+) Adult Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT01429610. IPD Sharing: Not stated. Countries: 1. Publications: 33.
Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00596804. IPD Sharing: Not stated. Countries: 2. Publications: 4.
Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)
ClinicalTrials.gov study NCT01458548. IPD Sharing: Not stated. Countries: 4. Publications: 2.
Phase I Study of Subcutaneous Ocaratuzumab in Patients With Previously Treated CD20+ B-Cell Malignancies
ClinicalTrials.gov study NCT01858181. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of T Specific Immune Response Against Delta-CD20 Peptide in Hematological Malignancies B
ClinicalTrials.gov study NCT02844491. IPD Sharing: Not stated. Countries: 1. Publications: 1.
OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients with CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine
ClinicalTrials.gov study NCT01478542. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20
ClinicalTrials.gov study NCT03097770. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dataset: On the Aggregation and Nucleation Mechanism of the Monoclonal Antibody Anti-CD20 Near Liquid- Liquid Phase Separation (LLPS)
<p>Dataset related to the paper: Pantuso et al., On the Aggregation and Nucleation Mechanism of the Monoclonal Antibody Anti-CD20 Near Liquid-Liquid Phase Separation (LLPS), Scientific Reports (2020) 10:8902.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.